The primary objective of the Endocrinology Training Program at the University of Massachusetts Medical School for the past 25 years has been that of the NRSA, namely """"""""...to prepare qualified individuals for careers that significantly impact the Nation's research agenda."""""""" Specifically, the Program's goal is to train both clinical (MD) and basic (PhD) scientists whose research will improve the care and outcome of endocrine diseases and diabetes mellitus. The majority of our trainees have entered competitive careers in academic research, government, and industry during the past 25 years. The Program has always focused on traditional endocrinology and diabetes research, but as this application reveals, the faculty has consistently sought to extend the breadth of the training to encompass cutting edge concepts and new technologies. New features capitalize on changes in endocrinology research and institutional growth. The Program design has been refined to provide a rich, intellectual research experience for talented, well-trained, and highly motivated postdoctoral M.D. and Ph.D. trainees. Five areas are emphasized: immunology of diabetes and islet transplantation, neuroendocrinology, cell signaling, bone disease, and steroid/reproductive endocrinology. All five areas are at the forefront of national priorities in endocrine research We propose to support 3 MD and 3 PhD trainees annually for a minimum of 2 years each. All trainees will be mentored throughout their fellowships to ensure continuity of research in endocrine and diabetes related research and clinical application of the research. A new recruitment initiative has been implemented, in collaboration with the American Board of Internal Medicine fast-track. We have recruited MD students to our program to permit their starting research during the third year of residency. MD trainees will have access to graduate school coursework in rapidly developing areas of molecular and cellular biology, whereas PhD trainees will attend special weekly seminars to expand clinical relevance of their research. There will be a formal mentoring committee to monitor each trainee's research progress. The University of Massachusetts Medical School has undergone major expansion of facilities and research opportunities. The mentoring faculty reflects this new growth, with particular depth in the five areas of emphasis. We believe that the proposed organizational and educational program will enhance the research experience of our trainees and address the nation's need for committed investigators in these important areas of medical and research need.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007302-30
Application #
7254282
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Hyde, James F
Project Start
1998-07-01
Project End
2008-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
30
Fiscal Year
2007
Total Cost
$317,535
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Pratap, Jitesh; Akech, Jacqueline; Wixted, John J et al. (2010) The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss. Mol Cancer Ther 9:3210-20
Becker, Klaus A; Ghule, Prachi N; Lian, Jane B et al. (2010) Cyclin D2 and the CDK substrate p220(NPAT) are required for self-renewal of human embryonic stem cells. J Cell Physiol 222:456-64
Guseva, Nina; Phillips, David; Mordes, John P (2010) Successful treatment of persistent hyperinsulinemic hypoglycemia with nifedipine in an adult patient. Endocr Pract 16:107-11
Becker, Klaus A; Stein, Janet L; Lian, Jane B et al. (2010) Human embryonic stem cells are pre-mitotically committed to self-renewal and acquire a lengthened G1 phase upon lineage programming. J Cell Physiol 222:103-10
Pfister, Edith L; Kennington, Lori; Straubhaar, Juerg et al. (2009) Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients. Curr Biol 19:774-8
Rossini, Aldo A; Greiner, Dale L (2007) Diabetes research in jeopardy: the extinction of clinical diabetes researchers. Ann N Y Acad Sci 1103:33-44
Gaur, S; Yamaguchi, H; Goodman, H M (2000) Activation of the sodium pump blocks the growth hormone-induced increase in cytosolic free calcium in rat adipocytes. Endocrinology 141:513-9
Colzani, R M; Alex, S; Fang, S L et al. (1999) Effects of iodine repletion on thyroid morphology in iodine and/or selenium deficient rat term fetuses, pups and mothers. Biochimie 81:485-91
Colzani, R M; Alex, S; Dunn, A D et al. (1999) The oral administration of human thyroglobulin does not affect the incidence of lymphocytic thyroiditis in the biobreeding Worcester rat. Thyroid 9:831-5
Colzani, R; Fang, S L; Alex, S et al. (1998) The effect of nicotine on thyroid function in rats. Metabolism 47:154-7

Showing the most recent 10 out of 41 publications